The Cancer Genome Atlas (TCGA) database revealed that YY2 was downregulated in HCC patients according to disease progression (TCGA dataset for liver HCC, n = 304; Figure S1D, Supporting Information). This evidence concerns the gene YY2 and hepatocellular carcinoma.